Papers/PMID:26599576
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
The Cochrane database of systematic reviews2015The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
methylphenidate — increases health-related quality of life
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“The change reported in a meta-analysis of three trials corresponds to a MD of 8.0 points (95% CI 5.49 to 10.46) on the CHQ, which suggests that methylphenidate may improve parent-reported quality of life (SMD 0.61, 95% CI 0.42 to 0.80; 3 trials, 514 participants; very low-quality evidence).”
Quoted verbatim from Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).. - Study
- meta-analysis
- Population
- Children and adolescents aged 18 years or younger with ADHD, parent-reported quality of life, meta-analysis of three trials against placebo or no intervention
Effect 0.61 standardised mean difference, 95% CI 0.42 to 0.8
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).2015PMID:26599576Permalink